Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation

TitleStrongyloidiasis pre and post autologous peripheral blood stem cell transplantation
Publication TypeJournal Article
Year of Publication2003
AuthorsOrlent H, Crawley C, Cwynarski K, Dina R, Apperley J
JournalBone marrow transplantation
Pagination115 - 117
Date PublishedJul
ISSN0268-3369; 0268-3369
Accession NumberPMID: 12815488; 1704104 [pii]
KeywordsAged, Antifungal Agents / therapeutic use, Humans, Immunosuppressive Agents / adverse effects / therapeutic use, Lymphoma, Large B-Cell, Diffuse / complications / therapy, Male, Middle Aged, Multiple Myeloma / complications / therapy, Peripheral Blood Stem Cell Transplantation / adverse effects / methods, Strongyloidiasis / chemically induced / diagnosis / drug therapy, Transplantation, Autologous

Hyperinfection with strongyloides stercolis occurs in the setting of chronic strongyloides infection in conjunction with immune suppression. Although malnutrition remains the major secondary cause worldwide in the developed world, iatrogenic immune suppression is an important precipitant. Autologous stem cell transplantation recipients are significantly immunocompromised albeit temporarily. Despite the increasing use of haemopoetic stem cell transplantation, hyperinfection with strongyloides has rarely been reported. We describe two cases of patients transplanted with chronic strongyloidiasis. In one case eradication therapy was given prior to the transplant which was uncomplicated. In the second case strongyloidiasis was diagnosed post transplant which was complicated by infection and respiratory compromise. Fatal hyperinfection subsequently developed after corticosteroid therapy was started for a disease progression in the CNS.

Alternate JournalBone Marrow Transplant.
Notify Library Reference ID1725

Related Incidents